Silence Therapeutics plc Stock
Stocks
SLN
US82686Q1013
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Nasdaq
05:57:40 15/08/26 am AEST
|
5-day change | 1st Jan Change | ||
| 13.74 USD | -1.61% |
|
+15.02% | +126.07% |
| 14/08 | European Equities Traded in the US Rise in Thursday Trading | MT |
| 12/08 | UK's Silence Therapeutics Prices $175 Million Offering in US | MT |
| Market Cap | 610M 826M 713M 670M 1.15B 78.99B 1.17B 7.86B 3.07B 39.56B 3.1B 3.03B 131B | P/E 2026 * |
-20.3x | P/E 2027 * | -16.8x |
|---|---|---|---|---|---|
| Enterprise Value | 477M 646M 558M 524M 896M 61.75B 911M 6.14B 2.4B 30.92B 2.42B 2.37B 103B | EV / Sales 2026 * |
1,468x | EV / Sales 2027 * | 581x |
| Free-Float |
69.35% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Silence Therapeutics plc
| 1 day | -1.61% | ||
| 1 week | +15.02% | ||
| Current month | +31.03% | ||
| 1 month | +25.87% | ||
| 3 months | +125.33% | ||
| 6 months | +208.88% | ||
| Current year | +126.07% |
| 1 week | 13.36 |  | 16.52 |
| 1 month | 10.16 | | 17.58 |
| Current year | 4.19 | | 17.58 |
| 1 year | 4.19 | | 17.58 |
| 3 years | 1.97 | | 27.72 |
| 5 years | 1.97 | | 27.72 |
| 10 years | 1.97 | | 35 |
| Manager | Title | Age | Since |
|---|---|---|---|
Iain Ross
CEO | Chief Executive Officer | 72 | 01/12/2025 |
Rhonda Hellums
DFI | Director of Finance/CFO | 54 | 01/02/2022 |
Curtis Rambaran
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
David Lemus
BRD | Director/Board Member | 63 | 21/06/2018 |
Iain Ross
CHM | Chairman | 72 | 01/01/2004 |
Tim McInerney
BRD | Director/Board Member | 65 | 05/05/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/7/26 | Sell | 865,112 | 0.6105% | |||
| 2/1/26 | Free | Chief Financial Officer | 375,000 | 0.2646% | ||
| 2/1/26 | Free | Director | 90,000 | 0.0635% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.61% | +15.02% | +150.59% | +111.46% | 826M | |
| +0.14% | -2.80% | +1.37% | +19.06% | 48.42B | |
| +0.85% | -0.70% | +460.88% | +581.30% | 43.66B | |
| -2.40% | -0.23% | +8.13% | +80.67% | 39.51B | |
| -2.01% | -0.85% | +23.85% | +9.97% | 38.95B | |
| -0.50% | +0.85% | +20.60% | +58.18% | 32.61B | |
| +0.38% | -3.23% | - | - | 16.32B | |
| -0.59% | -2.06% | +26.35% | +126.36% | 16.15B | |
| -1.45% | -0.89% | +3.09% | +26.68% | 14.16B | |
| -0.43% | +4.70% | +78.74% | +38.66% | 13.37B | |
| Average | -0.77% | +1.19% | +85.95% | +116.93% | 26.4B | |
| Weighted average by Cap. | -0.68% | -0.58% | +95.93% | +140.54% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 325K 440K 380K 357K 611K 42.07M 621K 4.18M 1.64M 21.07M 1.65M 1.62M 70.01M | 751K 1.02M 878K 825K 1.41M 97.23M 1.43M 9.67M 3.78M 48.69M 3.82M 3.73M 162M |
| Net income | -41.45M -56.15M -48.5M -45.58M -77.93M -5.37B -79.21M -534M -209M -2.69B -211M -206M -8.94B | -66.28M -89.8M -77.56M -72.88M -125M -8.59B -127M -854M -334M -4.3B -337M -330M -14.29B |
| Net Debt | -133M -180M -156M -146M -250M -17.24B -254M -1.71B -670M -8.63B -677M -662M -28.69B | -174M -236M -204M -191M -327M -22.55B -333M -2.24B -877M -11.29B -885M -866M -37.52B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/08/26 | USD 13.72 | -1.79% | 824,056 |
| 13/08/26 | USD 13.97 | +2.87% | 2,814,361 |
| 12/08/26 | USD 13.58 | -7.74% | 5,443,587 |
| 11/08/26 | USD 14.72 | -4.60% | 3,289,354 |
| 10/08/26 | USD 15.43 | +29.12% | 16,208,741 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SLN Stock
Select your edition
All financial news and data tailored to specific country editions
